Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Breast Cancer Stage III: early-phase trial registry
10 of 22 indexed Breast Cancer Stage III trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #756 of 28,707 conditions by registered trial count.
22 US clinical trials · 10 currently recruiting · #756 of 28,707 conditions by registered trial count
Breast Cancer Stage III: 22 US clinical trials tracked, 10 recruiting.
Breast Cancer Stage III is the subject of 22 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is Memorial Sloan Kettering Cancer Center, running 3 of these trials.
Enrollment posture brief
Registry condition breast-cancer-stage-iii
OPEN 10 | RECR 45% | LATE 1 | EARLY 8 | RANK #756 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Stroke (45% recruiting · 11 trials)
Breast Cancer Stage III lists 10 open slots (45% of 22 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Breast Cancer Stage III on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Breast Cancer Stage III is recruiting above its size-band peers.
10 of 22 indexed trials (45.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Breast Cancer Stage III trials is spread across many organizations.
Memorial Sloan Kettering Cancer Center accounts for 3 of 22 trials (13.6%). 17 distinct sponsors appear on at least one study for this condition label.
-
Typical Breast Cancer Stage III enrolment sits around 100 participants.
Median target enrolment is 100 among the 22 trials that report a genuine target (sentinel values excluded). 11 of those (50%) plan for fewer than 100 participants.
-
Breast Cancer Stage III research is mostly interventional.
19 interventional and 3 observational studies make up this index (86.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
22 total, page 1 of 1
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Weill Medical College of Cornell University
NCT06275126
A Study of Language Interpretation Solutions for People With Breast Cancer
Memorial Sloan Kettering Cancer Center
NCT06721065
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
Baylor Breast Care Center
NCT05020860
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
Fred Hutchinson Cancer Center
NCT06802172
Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy
Covenant Health Cancer Center
NCT06006806
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
UNC Lineberger Comprehensive Cancer Center
NCT06727773
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
George Washington University
NCT06806930
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
University of California, Davis
NCT06268665
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
University of Virginia
NCT05288777
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Emory University
NCT05877859
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
Alliance for Clinical Trials in Oncology
NCT03766009
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection
Alliance for Clinical Trials in Oncology
NCT03927027
Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors
SystImmune
NCT06714617
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
NCT03384914
Taking AIM at Breast Cancer
Dana-Farber Cancer Institute
NCT04720209
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients
Massachusetts General Hospital
NCT03270072
Ultrahypofractionation and Normal Tissue Toxicity
Massachusetts General Hospital
NCT05912231
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
NCT04180579
CARE (Chemotherapy Alopecia REduction)
George Washington University
NCT07201389
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
Memorial Sloan Kettering Cancer Center
NCT05036252
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors
Case Comprehensive Cancer Center
NCT06336538
Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors
Ohio State University Comprehensive Cancer Center
NCT02150525
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 7 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Breast Cancer Stage III records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Breast Cancer Stage III trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Breast Cancer Stage III page
22 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 10 Breast Cancer Stage III trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Memorial Sloan Kettering Cancer Center sponsors the most Breast Cancer Stage III trials on record, review their full trial history before evaluating a specific study. See Memorial Sloan Kettering Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Breast Cancer Stage III condition card totals 22 registered trials; most-linked intervention Questionnaire Administration; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.